안과 진단 시장 : 제품별, 용도별, 최종 용도별, 예측(2023-2032년)

Global Ophthalmology Diagnostics Market will expand at a recognizable CAGR between 2023 and 2032, attributed to the rising prevalence of eye disorders and diseases such as cataracts, glaucoma, and macular degeneration, fueling the demand for efficient diagnostic tools. The consistent rise in the aging population worldwide has led to a surge in age-related eye conditions, contributing to market growth and advancement. According to the American Academy of Opthalmology, more than 24.4 million Americans aged 40 and older have cataracts, while the condition affects nearly half of all Americans by age 75. Similarly, over 2.7 million people aged 40 and older in the country have glaucoma.

Technological advancements in imaging techniques, such as optical coherence tomography (OCT) and fundus photography, have revolutionized ophthalmic diagnostics, providing accurate and detailed evaluations. Moreover, the growing awareness about early detection and timely treatment of eye diseases, in line with the availability of advanced ophthalmology diagnostic devices, will propel market gains. Furthermore, favorable reimbursement policies and government initiatives focused on improving eye care services are positively influencing the industry landscape.

The overall ophthalmology diagnostics market is segregated based on product, application, end-use, and region.

Regarding the product, the specular microscopes segment will drive noticeable gains through 2032. The demand for specular microscopes is growing due to their critical role in assessing the health of corneal endothelial cells. These microscopes provide high-resolution imaging of the cornea's innermost layer, allowing for early detection and monitoring of conditions like Fuchs' endothelial dystrophy and corneal edema. With the increasing prevalence of corneal diseases and the need for precise evaluation, specular microscopes have become indispensable tools in ophthalmic clinics and surgical centers.

With respect to application, the ophthalmology diagnostics market share from the refractive errors segment will register commendable growth over 2023-2032. Refractive errors such as myopia, hyperopia, and astigmatism are highly prevalent worldwide, leading to a substantial patient population seeking vision correction. Additionally, advancements in diagnostic technologies, such as wavefront aberrometry and corneal topography, enable precise measurements and personalized treatment approaches. Moreover, the growing awareness about the impact of refractive errors on quality of life and the availability of effective treatment options like LASIK and refractive lens exchange has further fueled the demand for ophthalmology diagnostics in this area.

Ophthalmic clinics could dominate the end-use spectrum of the ophthalmology diagnostics industry from 2023 to 2032. There is an increasing prevalence of eye diseases and conditions, necessitating accurate and efficient diagnostic tools. Additionally, advancements in diagnostic technologies allow for early detection, precise evaluation, and tailored treatment plans. Moreover, with a focus on providing comprehensive eye care, ophthalmic clinics are recognizing the importance of investing in cutting-edge diagnostics to enhance patient care and outcomes.

Asia Pacific ophthalmology diagnostics market will exhibit sizeable growth through 2032 due to the increasing population and aging demographics contributing to a higher incidence of eye disorders, driving the need for efficient diagnostics. Additionally, improving healthcare infrastructure, rising disposable incomes and increasing awareness about eye health are fueling the demand for advanced diagnostic technologies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Ophthalmology Diagnostics industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Regional trends
• 2.4 Product trends
• 2.5 Application trends
• 2.6 End-use trends

Chapter 3 Ophthalmology Diagnostics Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in number of people suffering from ophthalmic disorders
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Favourable government initiatives
    • 3.2.1.4 Rising demand for early diagnosis and control of vision loss
    • 3.2.1.5 Diagnostic advantages in eye testing
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of the ophthalmology diagnostic devices
    • 3.2.2.2 Lack of skilled professionals
    • 3.2.2.3 Increasing adoption of refurbished ophthalmic devices
• 3.3 Growth potential analysis
  • 3.3.1 By product
  • 3.3.2 By application
  • 3.3.4 By end use
• 3.4 COVID- 19 impact analysis
• 3.5 Pricing analysis, 2022
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Technology landscape
• 3.8 Future market trends
• 3.9 Gap analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company market share analysis, 2022
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard

Chapter 5 Ophthalmology Diagnostics Market Size and Forecast, By Product (USD Million)

• 5.1 Key trends, by product
• 5.2 Autorefractor
• 5.3 Biometer
• 5.4 Corneal topography systems
• 5.5 Fundus cameras
• 5.6 Keratometers
• 5.7 Lensometers
• 5.8 Ophthalmic ultrasound imaging systems
• 5.9 Ophthalmoscopes
• 5.10 Optical biometry systems
• 5.11 Optical coherence tomography scanner
• 5.12 Pachymeter
• 5.13 Perimeters/visual field analyzers
• 5.14 Phoropters
• 5.15 Retinoscopes
• 5.16 Slit lamps
• 5.17 Specular microscopes
• 5.18 Tonometer
• 5.19 Wavefront aberrometers
• 5.20 Others

Chapter 6 Ophthalmology Diagnostics Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Cataracts
• 6.3 Glucoma
• 6.4 Vitreoretinal diseases
• 6.5 Refractive errors
• 6.6 Surgical assessment
• 6.7 Others

Chapter 7 Ophthalmology Diagnostics Market Size and Forecast, By End-use (USD Million)

• 7.1 Key trends, by end-use
• 7.2 Hospitals
• 7.3 Ophthalmic Clinics
• 7.4 Ambulatory Surgical Centers
• 7.5 Others

Chapter 8 Ophthalmology Diagnostics Market Size and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Poland
  • 8.3.7 Sweden
  • 8.3.8 The Netherlands
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Thailand
  • 8.4.7 Indonesia
  • 8.4.8 Philippines
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Columbia
  • 8.5.5 Chile
  • 8.5.6 Peru
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Israel
  • 8.6.5 Turkey
  • 8.6.6 Iran

Chapter 9 Company Profiles

• 9.1 Alcon Vision LLC
• 9.2 Bausch & Lomb Incorporated
• 9.3 Canon
• 9.4 Carl Zeiss Meditec AG
• 9.5 Essilor International S.A
• 9.6 Johnson & Johnson Vision Care
• 9.7 Lumenis Ltd
• 9.8 Lumibird Group
• 9.9 Marco Ophthalmic Inc.
• 9.10 Metall Zug Group
• 9.11 Nidek Co. Ltd
• 9.12 Topcon Corporation
• 9.13 Ziemer Ophthalmic Systems AG|